Interestingly, considering that CCS52B expression is restricted to early phases of the cell cycle (G2/M and M-phase) unlike the A-types (late M-phase to G2-phase) effect of MTX on CCS52B expression goes in accordance with mediation of mitotic cell cycle arrest at S phase
PubMed Central , Methods in Molecular Biology (Clifton, N.J.) , vol
Tesamorelin binds the GHRH receptor on anterior pituitary somatotrophs with affinity comparable to native GHRH
Furthermore, the 5 mg, 10 mg, and 15 mg doses exhibited superior weight loss and glycemic control relative to dulaglutide (1.5 mg), while maintaining an acceptable safety and tolerability profile
PMID: 41468591
This means that the drug targets not one, but two unique incretin hormones produced by the human bodywhich has been shown to increase the efficacy of the drug compared to medications that target only GLP-1